Instagram story viewer> @aminoaiapp> Posts

Amino Ai

@aminoaiapp

8

followers

9

following

For people who want to hit their goals without ever missing a dose.
Track your cycles, progress and more.
Early access ↓

POSTS STORIES REELS TAGGED

Download All

This is the rare research peptide where we can say something definitive, and that is exactly why it is worth a post.

Most compounds sold this way have no human data at all, so the honest answer is always that nobody looked. Here somebody did look, six times, across 893 participants between 2001 and 2006.

The safety record that came out of it is genuinely good, with adverse events indistinguishable from placebo and no antibody response.

What did not come out of it was an effect worth having. Two details about the paper trail matter more than any number. The positive twelve-week result was presented at a conference in 2005 and never written up as a full study. Searching the medical literature for it returns nothing.

And the larger trial that failed has never been published at all, in any journal, ever. Its outcome survives in a stock exchange announcement from February 2007 and a single sentence in a later company review admitting the effect was not seen once an intensive diet and exercise regime was included.

A negative result that expensive should be in the literature, and it is not.

Two more things repeated online that do not survive checking. The beta-3 receptor mechanism people cite comes from a paper whose authors concluded the fat-burning is not directly mediated by that receptor. And the joint and cartilage claims rest entirely on one 2015 study in 32 rabbits.

There has never been a human trial of this compound for osteoarthritis. For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoaiapp for more peptide research without the hype. by @aminoaiapp

45

1

a month ago

Two things get repeated about this peptide that did not survive checking, and the corrected versions are better stories.

The first is the longevity gene. A 2015 paper proposed that a variant common in northeast Asian populations might explain exceptional lifespan, and it travelled widely.

That paper was a hypothesis piece with no cohort data of its own, and its own title ended in a question mark.

The same research group then went and tested it in 736 Japanese centenarians. The variant showed up in 7.7% of them against 7.5% of controls, which is nothing.

What they found instead, across more than 27,000 people, is that men carrying it have higher rates of type 2 diabetes, and that the effect sits almost entirely in the least physically active third.

Active carriers showed no elevation at all. A gene variant whose downside only appears if you do not move is a far more interesting finding than a longevity gene that was not there.

The second is that exercise reliably raises it in humans. That comes from one study of ten sedentary young men, where muscle levels rose almost twelve fold.

A larger study of thirty people, comparing endurance against resistance training, did not clearly reproduce it for this peptide, though it did for a related one.

Worth knowing on development: the only company that ever put a molecule based on this into humans tested an analog rather than the peptide itself, saw liver enzymes improve but liver fat unchanged, deemed the formulation unsuitable, and pivoted the entire business into cancer immunotherapy.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoaiapp for more peptide research without the hype. by @aminoaiapp

155

0

a month ago

Your side effects might be coming from one mistake, and we watched thousands of people make it.

Before we built Amino AI, we asked more than 3,000 peptide researchers on our private list how they were actually running their cycles.

What came back was chaos.

They were guessing their doses, injecting on no real schedule, keeping no record of their results or their side effects, and rotating injection sites at random.

That is the mistake: running blind.

When you write nothing down, you can’t tell whether a rough day came from the peptide, the dose, or a mix you forgot you took.

And that is a lot of risk to carry for something you are paying good money to put into your own body.

So we built Amino AI to take the confusion out of the whole thing.

It keeps your doses, your timing, your injection sites, your results, and your side effects in one place, so you stop missing doses, stop overdoing it, and stop throwing away a cycle you worked hard to set up.

Two minutes to set up, one tap to log, and it never nags you.

And the more you run your cycles inside it, the sharper it gets.

Every time you tell us what could be better, you are helping yourself and everyone else run a little safer.

We are just getting started.

The Amino family is growing, and we would love for you to be part of it.

See you around.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoaiapp for more peptide research without the hype. by @aminoaiapp

13

0

a month ago

D!h€xa is the poster child for brain-peptide hype, and the wild part is that the headline number is real.

In a lab dish it grew new synapses at doses around ten million times lower than BDNF, your brain’s own growth factor.

That’s a genuine, measured result. Here’s what that number is not. It’s a single narrow test of potency in cultured cells, not a measure of how much sharper anyone got.

D!h€xa was engineered as an angiotensin IV analog to reach the brain and build synaptic connections through the HGF and c-Met system, and in animals it did.

Then the twist. The studies that built the legend have not held up. A central 2014 paper from the original lab was retracted in 2025, and the 2013 paper carries a formal notice of concern.

No human trial has ever tested it for safety or memory. Brilliant idea, real mechanism, shaky evidence. A molecule to watch, not to buy.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

14 hours ago

€p!talon is the peptide the longevity crowd treats like a cheat code, the one that supposedly resets your telomeres and buys you decades.

The core science is genuinely real. The catch is where it all comes from.

It started in the Soviet Union. Professor Vladimir Khavinson and his team at the St Petersburg Institute of Gerontology spent decades on short peptides they call bioregulators, and €p!talon, a synthetic copy of a pineal-gland extract, became the star of that work. In cultured human cells it switched telomerase back on and lengthened telomeres, the caps that protect your DNA every time a cell divides.

In animals it stretched lifespan by 15 to 30% and lowered tumour rates, and a long Russian trial in elderly heart patients reported fewer deaths. It was even studied in a blinding retinal disease, with reported improvement. Now the honest part.

Almost all of that evidence traces back to Khavinson’s own lab, with little independent replication in the West, and it is not FDA approved. A result nobody outside one group has reproduced is a result on probation, however good it sounds.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

2 days ago

Every fat-loss peptide claims to melt visceral fat. T€samorel!n is the rare one the FDA actually agreed with.

It’s a stabilised form of GHRH, the hormone that tells your pituitary to release growth hormone. Instead of injecting GH, it prompts your body to make more of its own, which then helps break down the deep fat wrapped around your organs.

That’s not a supplement pitch, it’s the mechanism behind a real 2010 approval, originally for the stubborn belly fat that builds up in some people with HIV. In its phase 3 program it measurably cut visceral fat and improved metabolic markers in hundreds of people.

The honest part. The fat comes back if you stop, it pushes up IGF-1 and needs monitoring, and almost all the strong data sits in one patient group. Real, approved, and still not a shortcut.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

4 days ago

M€tform!n, ₿erber!ne and MOT$-c all get sold as the key to blood sugar and longevity, and the loudest one has the least behind it.

M€tform!n is the unglamorous winner. It tells the liver to make less sugar, and UKPDS 34 showed it cut real complications, which is why it’s now studied for ageing itself. ₿erber!ne hits the same AMPK energy switch, and a 2008 clinical study found real but modest glucose drops, though the trials are small.

MOT$-c is the exciting one, a peptide your own mitochondria make that behaved like exercise in mice, but the human research has barely started. Notice the pattern. The hype runs opposite to the evidence. That’s the tell worth carrying into every peptide claim you see.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

2

0

6 days ago

Most peptides sold online are research-grade guesses.

Thymos!n Alpha-! is not one of them, and that’s worth saying plainly. It’s a fragment of a real thymus hormone, and it genuinely helps mature the T-cells your immune system learns with.

In dozens of countries it’s an approved drug, sold as Zadaxin, mostly for chronic hepatitis B and C, and it’s studied as a booster that helps vaccines work better.

Decades of real clinical use put it in a different tier from almost everything else in this space. The honest limit. It’s legitimate, not magic.

In a large, double-blind 2025 sepsis trial it did not lower deaths versus placebo, and it’s still not approved in the US. A genuinely useful immune peptide, minus the cure-all story it gets sold with.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

7 days ago

Peptides get sold as clean, natural and basically consequence-free.

Here’s what no influencer will ever tell you. The common ones are mostly boring. GLP-1 drugs bring nausea, sometimes vomiting or constipation, usually easing after a few weeks.

Growth-hormone peptides can hold water, cause tingling or numb hands, and nudge blood sugar and IGF-1 up. Anything injected can leave redness or lumps, occasionally an immune reaction, and an infection if the technique is careless.

The one that actually deserves your attention is the vial. Most peptides bought as research-only skip quality control entirely, so the purity and the real dose are frequently wrong, and contamination is a documented problem.

In plenty of cases the scariest ingredient is the one nobody put on the label. Respect the molecule, and respect the source even more.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

9 days ago

There’s a whole corner of brain-peptide research that basically lives in Russian, and the West has never bothered to check it.

Two peptides lead it, and both are prescribed drugs there.

$€max is the focus one, an ACTH fragment used for concentration and stroke recovery that raises BDNF in animal work.

$€lank is the calm one, built from an immune peptide called tuftsin, and a 2008 Russian trial reported it eased generalised anxiety and burnout without heavy sedation.

The honest part. The evidence is real but narrow, mostly from one country and one era, with little independent Western replication. Neither is FDA approved. Genuinely used, genuinely under-tested by outside eyes.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

9 days ago

The peptides people take for their own recovery are quietly showing up somewhere new: the vet’s office.

A growing wave of integrative vets is using peptides off-label in dogs, mostly for aching joints, gut trouble, and healing after injuries or surgery. The logic is simple. Peptides are short signals that tell the body to repair itself, and a dog runs the same repair machinery we do.

Two names come up most. ₿P₡-!57, aimed at the gut and the joints, and T₿-500, used for soft-tissue repair like muscle tears, ligament sprains, and slow post-surgery healing. The two are often run together.

Vets describe dogs with chronic gut issues settling down and older dogs bouncing back faster than expected. So why is this booming now? Dogs are living longer, surgeries cost thousands, and owners who already trust peptides for themselves are asking for them for their pets.

Here’s the honest part: almost none of this rests on real canine trials. It is borrowed from human and rodent data, and no peptide is FDA-approved for pets, which puts sourcing and safety squarely on the owner and their vet. The evidence is thin and the hype is loud, but serious vets are watching for a reason.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app (http://aminoai.app/) for more peptide research without the hype. by @aminoaiapp

3

0

10 days ago

Snoring gets treated as a punchline, and for a lot of people it’s the loudest symptom of something serious.

When the airway keeps collapsing in sleep, oxygen dips over and over, the heart works harder, and the days feel foggy no matter how long you were in bed.

That’s obstructive sleep apnea, and extra weight is one of its biggest drivers. Then the data landed.

In the 2024 SURMOUNT-OSA trial, T!rz€patide, the GLP-1 and GIP drug better known for weight loss, cut apnea events by up to 63%, about 30 fewer breathing interruptions an hour, and roughly half of patients hit the criteria for disease resolution.

R€tatrut!de, the newer and stronger triple agonist, is driving even bigger weight loss, so the same benefit is expected to follow.

The honest part. It works by removing the weight pressing on the airway, so it helps most when weight is the driver, and it carries the usual gut side effects.

For educational purposes only. Not medical advice. Most peptides are not FDA approved and are for research purposes only.

Follow @aminoai.app for more peptide research without the hype. by @aminoaiapp

3

0

12 days ago